サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1786450

DLIFおよびXLIFインプラントの世界市場

DLIF and XLIF Implants

出版日
ページ情報
英文 278 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.46円
DLIFおよびXLIFインプラントの世界市場
出版日: 2025年08月08日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 278 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

DLIFおよびXLIFインプラントの世界市場は2030年までに18億米ドルに達する

2024年に15億米ドルと推定されるDLIFおよびXLIFインプラントの世界市場は、2024年から2030年にかけてCAGR 2.6%で成長し、2030年には18億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである椎間板変性疾患アプリケーションは、CAGR 3.1%を記録し、分析期間終了時には8億2,180万米ドルに達すると予測されます。脊椎すべり症アプリケーションの成長率は、分析期間中CAGR 2.6%と推定されます。

米国市場は4億2,090万米ドルと推定、中国はCAGR5.0％で成長予測

米国のDLIFおよびXLIFインプラント市場は、2024年に4億2,090万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを5.0%として、2030年までに3億4,760万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ0.9％と1.9％と予測されています。欧州では、ドイツがCAGR 1.4%で成長すると予測されています。

世界のDLIFおよびXLIFインプラント市場- 主要動向と促進要因まとめ

低侵襲脊椎手術の台頭がDLIFおよびXLIFインプラントの需要を後押し？

過去10年間、脊椎外科の分野では、低侵襲手術（MIS）手技に対する臨床的・患者的嗜好の高まりとともに、大きなパラダイムシフトが起きています。中でも最も革新的な技術革新は、Direct Lateral Interbody Fusion（DLIF）とExtreme Lateral Interbody Fusion（XLIF）であり、外科医は従来の前方や後方からのアプローチではなく、側方からのアプローチで腰椎にアクセスすることができます。これらの手技は、筋肉や組織へのダメージを最小限に抑え、術中の出血を減らし、入院期間を短縮し、患者の回復を早めることを目的としています。このような手技の人気が高まっているのは、特に高齢化社会における脊椎疾患の世界の増加によるところが大きいです。腰椎変性椎間板症、脊椎すべり症、脊柱管狭窄症などの疾患は、人々が長生きし、高齢になっても活動的なライフスタイルを維持するにつれて、より一般的になってきています。DLIFおよびXLIFインプラントは、このような手術中に脊柱を安定させ、再調整する中心的な役割を担っており、患者の罹患率を最小限に抑えながら癒合を成功させることができるため、勢いを増しています。病院や外来手術センターもまた、侵襲の少ない治療モデルへの広範な組織的コミットメントを反映し、これらの手技をサポートする機器やトレーニングに投資しています。外科医は、臨床的な利点だけでなく、ワークフローの改善と手術時間の短縮のために、ますますこれらのアプローチに惹かれるようになっています。さらに、これらのインプラントは、最先端の術中神経モニタリングや画像ガイダンスと組み合わせて使用されることが多く、手術の精度を高め、合併症のリスクを軽減しています。医療関係者がこれらの技術を採用し、改良を続けるにつれて、DLIFおよびXLIFインプラントの需要は着実に伸びると予想され、脊椎固定術の将来にとって不可欠なものとなっています。

インプラント材料の革新は市場力学をどのように形成しているか？

材料科学は、DLIFおよびXLIFインプラント市場における技術革新の最前線にあり、新しい組成と構造の進歩により、インプラントの性能と患者の予後を大幅に向上させています。従来、チタンはその強度と生体適合性から選ばれる材料であったが、放射線不透過性であるため術後の画像診断が困難でした。そのため、PEEK（ポリエーテルエーテルケトン）のような、放射線不透過性で術後の骨癒合の評価が容易な素材へとシフトしてきました。さらに、PEEKの弾性率は天然骨に近いため、応力の遮蔽が少なく、骨のリモデリングをより健全に促進します。近年では、ポーラスチタンや、PEEKとチタンを組み合わせたハイブリッド素材が、視認性、骨統合性、構造的完全性のバランスを取ることができるため、人気を博しています。もうひとつの画期的な開発は、3Dプリンティング技術を利用し、海綿骨を模倣したカスタマイズされた多孔質構造を持つインプラントを製造することで、自然な骨の新生を促しています。これらの付加的に製造されたインプラントは、患者固有の解剖学的要件に合わせて調整することもでき、適合性を向上させ、合併症のリスクを低減します。さらに、多くの企業がナノテクスチャリングや生物活性コーティングなどの表面治療を取り入れており、細胞接着を強化し、オッセオインテグレーションを促進しています。これらの技術革新により、癒合時間が短縮され、脊柱手術の長期的な成功率が高まる。インプラントの設計が進化を続けるにつれ、機械的安定性だけでなく、生物学的な利点ももたらす多機能インプラントに注目が集まっています。このような先端材料による優れた治療成績が臨床研究で証明され始め、病院や手術センターの購入決定に影響を与えています。この技術的飛躍は、材料科学者、生物医学エンジニア、および整形外科医が、現代の脊椎治療においてインプラントが達成できる限界を押し広げようと協力していることでも後押しされています。

ヘルスケアインフラの変化と償還政策が市場アクセシビリティを変える？

ヘルスケア提供の世界の状況は大きく変化しており、こうした変化はDLIFおよびXLIFインプラントの採用に大きな影響を与えています。米国、ドイツ、日本などの先進国では、確立されたヘルスケア・インフラと包括的な保険適用があるため、これらのインプラントを日常的な外科手術に迅速に組み込むことが可能になっています。米国では、メディケアや民間保険会社による有利な償還政策が、DLIFやXLIF手術に必要な専門的訓練や設備への投資を病院に促しています。このような財政的支援により、中規模のヘルスケア施設であっても、これらの高度な手技を採用することが可能になっています。逆に、アジア、ラテンアメリカ、中東の一部の新興国市場では、医療制度がさまざまな発展段階にあり、こうした技術の導入を促進したり、妨げたりしています。しかし、これらの地域では、ヘルスケア・サービスの近代化と拡大という明確な傾向が見られます。政府は医療インフラに多額の投資を行っており、民間病院チェーンが急増し、増加する中産階級に高級脊椎手術を提供しています。国際的な脊椎脊髄学会や世界の医療技術企業が主導する研修プログラムは、ラテラルアクセス・フュージョン技術に関する現地の外科医のスキルアップに役立っており、市場拡大の原動力となっています。同時に、診療報酬モデルも進化しており、DLIFとXLIFの特徴である臨床効果とコスト効率に報いる価値ベースの医療に移行する国が増えています。さらに、特に米国と西欧では外来脊椎手術が増加しており、より短時間で侵襲の少ない手術に適合するインプラントへの需要が加速しています。また、一括支払いとエピソード・ベースの償還への注目の高まりは、合併症と再入院を最小限に抑えるインプラント・ソリューションを選択するよう病院を促しています。このような制度的変化により、DLIFおよびXLIFインプラントへのアクセスは再構築され、その利用可能性は民主化され、世界の脊椎外科エコシステムにおける役割も拡大しています。

DLIFおよびXLIFインプラントの市場拡大の真の原動力は？

DLIFおよびXLIFインプラント市場の成長は、技術革新、人口動態の変化、外科手術の進化、エンドユーザーの期待に深く結びついたいくつかの要因によってもたらされています。最も重要な原動力の一つは、変性脊椎疾患や外傷性損傷の有病率の増加であり、これが効果的で信頼性の高い脊椎固定術の必要性を煽っています。低侵襲性で知られるDLIFやXLIF手技は、こうした場面で選択される手技になりつつあり、そこで使用されるインプラントの需要も高まっています。手術ナビゲーション、ロボット支援、術中画像診断の技術的進歩も重要な要素であり、これらのツールは非常に正確なインプラントの埋入を可能にするため、臨床結果と外科医の信頼性を向上させています。同様に重要なのは、外科的嗜好の変化です。整形外科医や神経外科医は、筋肉の大きな損傷を避け、入院期間を短縮できることから、側方からのアプローチをますます好むようになっています。患者側では、回復が早く、痛みが少なく、瘢痕が最小限に抑えられる手術に対する需要が高まっており、DLIFやXLIF手術は、適切なインプラントと組み合わせることで、そのすべてを約束します。外来手術センター（ASCs）や当日退院オプションの動向も、短時間で高効率の手術をサポートするインプラントへの需要を促進しています。さらに、このニッチ分野への新興企業や既存医療技術企業の参入により、研究開発努力が強化され、特定の患者グループ、脊髄病態、外科医の嗜好に合わせて調整された、より多様で高度な製品が提供されるようになっています。市場参入企業はまた、病院や研究機関との戦略的提携に注力し、インプラント、器具、ナビゲーションツール、トレーニングモジュールなどを統合した包括的な手技エコシステムの構築に取り組んでいます。このような相乗効果により、手術プロセスが合理化され、ヘルスケアプロバイダーの価値が向上しています。最後に、データ主導の転帰と長期的な費用対効果が重視されるようになったことで、医療機関は再手術率が低く、患者の満足度が高いインプラントシステムを好むようになり、世界の脊椎インプラント市場におけるDLIFおよびXLIFインプラントの地位は確固たるものとなっています。

セグメント

用途（椎間板変性疾患用途,脊椎すべり症用途,脊柱側弯症用途,その他の用途）;最終用途（病院最終用途,外来患者施設最終用途）

調査対象企業の例

  • Alphatec Holdings, Inc.（ATEC Spine）
  • Aurora Spine Corporation
  • B. Braun Melsungen AG
  • Captiva Spine, Inc.
  • Centinel Spine, LLC
  • CoreLink, LLC
  • Curiteva
  • DePuy Synthes（Johnson & Johnson）
  • Exactech, Inc.
  • Globus Medical, Inc.
  • K2M Group Holdings, Inc.
  • Life Spine, Inc.
  • LDR Holding Corporation
  • Medtronic plc
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • Osseus Fusion Systems
  • RTI Surgical Holdings, Inc.
  • SeaSpine Holdings Corporation
  • Spinal Elements, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP30553

Global DLIF and XLIF Implants Market to Reach US$1.8 Billion by 2030

The global market for DLIF and XLIF Implants estimated at US$1.5 Billion in the year 2024, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 2.6% over the analysis period 2024-2030. Degenerative Disc Diseases Application, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$821.8 Million by the end of the analysis period. Growth in the Spondylolisthesis Application segment is estimated at 2.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$420.9 Million While China is Forecast to Grow at 5.0% CAGR

The DLIF and XLIF Implants market in the U.S. is estimated at US$420.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$347.6 Million by the year 2030 trailing a CAGR of 5.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.9% and 1.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.4% CAGR.

Global DLIF and XLIF Implants Market - Key Trends & Drivers Summarized

Is the Rise of Minimally Invasive Spine Surgeries Fueling the Demand for DLIF and XLIF Implants?

Over the past decade, the field of spine surgery has witnessed a significant paradigm shift, with growing clinical and patient preference for minimally invasive surgical (MIS) techniques. Among the most transformative innovations are Direct Lateral Interbody Fusion (DLIF) and Extreme Lateral Interbody Fusion (XLIF), which allow surgeons to access the lumbar spine through a lateral approach rather than the traditional anterior or posterior route. These procedures are designed to minimize damage to muscles and tissues, reduce intraoperative blood loss, shorten hospital stays, and enable faster patient recovery. The increasing popularity of these techniques is largely driven by the global rise in spinal disorders, especially among the aging population. Conditions such as lumbar degenerative disc disease, spondylolisthesis, and spinal stenosis are becoming more prevalent as people live longer and maintain active lifestyles well into old age. DLIF and XLIF implants, which play a central role in stabilizing and realigning the spine during these procedures, are gaining momentum due to their ability to facilitate successful fusions with minimal patient morbidity. Hospitals and ambulatory surgical centers are also investing in equipment and training that support these techniques, reflecting a broader institutional commitment to less invasive care models. Surgeons are increasingly drawn to these approaches not only for their clinical benefits but also for improved workflow and reduced surgical times. Moreover, these implants are often used in combination with cutting-edge intraoperative neuromonitoring and imaging guidance, enhancing surgical accuracy and reducing the risk of complications. As medical professionals continue to adopt and refine these techniques, the demand for DLIF and XLIF implants is expected to grow steadily, making them integral to the future of spinal fusion surgeries.

How Are Innovations in Implant Materials Shaping Market Dynamics?

Material science is at the forefront of innovation in the DLIF and XLIF implants market, with new compositions and structural advancements significantly enhancing implant performance and patient outcomes. Traditionally, titanium was the material of choice due to its strength and biocompatibility, but its radiopaque nature made post-surgical imaging more difficult. This has led to a shift toward materials such as PEEK (polyether ether ketone), which offers radiolucency, allowing for easier post-operative assessments of bone fusion. Furthermore, PEEK's elastic modulus closely matches that of natural bone, reducing stress shielding and promoting healthier bone remodeling. In recent years, porous titanium and hybrid materials combining PEEK and titanium have gained popularity due to their ability to balance visibility, osteointegration, and structural integrity. Another groundbreaking development is the use of 3D printing technology to manufacture implants with customized porous architecture that mimics cancellous bone, which encourages natural bone in-growth. These additively manufactured implants can also be tailored to patient-specific anatomical requirements, improving fit and reducing the risk of complications. Additionally, many companies are incorporating surface treatments such as nano-texturing and bioactive coatings that enhance cell adhesion and accelerate osseointegration. These innovations reduce fusion time and increase the long-term success of spinal procedures. As implant designs continue to evolve, there is a growing focus on multi-functional implants that not only provide mechanical stability but also deliver biological benefits. Clinical studies have begun to document superior outcomes with these advanced materials, influencing purchasing decisions at hospitals and surgical centers. This technological leap is also being fueled by collaborations between material scientists, biomedical engineers, and orthopedic surgeons who are working together to push the boundaries of what implants can achieve in modern spine care.

Are Shifting Healthcare Infrastructures and Reimbursement Policies Altering Market Accessibility?

The global landscape of healthcare delivery is undergoing profound changes, and these shifts are significantly impacting the adoption of DLIF and XLIF implants. In developed nations such as the United States, Germany, and Japan, the presence of well-established healthcare infrastructure and comprehensive insurance coverage has enabled rapid integration of these implants into routine surgical practice. In the U.S., favorable reimbursement policies under Medicare and private insurers have encouraged hospitals to invest in the specialized training and equipment necessary for DLIF and XLIF procedures. This financial support has made it feasible for even mid-sized healthcare facilities to adopt these advanced techniques. Conversely, in emerging markets across Asia, Latin America, and parts of the Middle East, healthcare systems are at varying stages of development, which can either facilitate or hinder the adoption of these technologies. However, there is a clear trend toward modernization and expansion of healthcare services in these regions. Governments are investing heavily in medical infrastructure, and private hospital chains are proliferating, offering high-end spinal surgeries to a growing middle class. Training programs led by international spine societies and global medtech firms are helping to upskill local surgeons in lateral access fusion techniques, thereby driving market expansion. At the same time, reimbursement models are evolving, with more countries moving toward value-based care that rewards clinical efficacy and cost-efficiency-two hallmarks of DLIF and XLIF. Additionally, the rise of outpatient spinal surgeries, particularly in the U.S. and Western Europe, is accelerating demand for implants that are compatible with shorter, less invasive procedures. The increased focus on bundled payments and episode-based reimbursements is also encouraging hospitals to choose implant solutions that minimize complications and readmissions. These systemic changes are reshaping access to DLIF and XLIF implants, democratizing their availability and expanding their role in the global spine surgery ecosystem.

What’s Truly Powering the Market Expansion for DLIF and XLIF Implants?

The growth in the DLIF and XLIF implants market is driven by several factors that are deeply tied to innovation, demographic shifts, surgical evolution, and end-user expectations. One of the most significant drivers is the increasing prevalence of degenerative spinal conditions and trauma-induced injuries, which are fueling the need for effective and reliable spinal fusion procedures. DLIF and XLIF techniques, known for their minimally invasive nature, are becoming the procedures of choice in these scenarios, and the implants used in them are in growing demand. Technological progress in surgical navigation, robotic assistance, and intraoperative imaging is another critical factor; these tools allow for highly precise implant placement, thereby improving clinical outcomes and surgeon confidence. Equally important is the shift in surgical preferences-orthopedic surgeons and neurosurgeons are increasingly favoring lateral approaches due to their ability to avoid major muscle disruption and reduce hospital stays. On the patient side, there is a rising demand for surgeries that allow quicker recovery, less pain, and minimal scarring, all of which DLIF and XLIF procedures promise when paired with the right implants. The expanding trend of ambulatory surgical centers (ASCs) and same-day discharge options is also fueling demand for implants that support short-duration, high-efficiency procedures. Furthermore, the entry of startups and established medtech companies into this niche is intensifying R&D efforts, leading to more diverse and advanced product offerings tailored for specific patient groups, spinal pathologies, and surgeon preferences. Market players are also focusing on strategic collaborations with hospitals and research institutions to create comprehensive procedural ecosystems that integrate implants, instruments, navigation tools, and training modules. These synergies are streamlining the surgical process and creating value for healthcare providers. Lastly, the growing emphasis on data-driven outcomes and long-term cost-effectiveness is prompting institutions to favor implant systems that demonstrate lower revision rates and better patient satisfaction, cementing the position of DLIF and XLIF implants in the global spinal implants market.

SCOPE OF STUDY:

The report analyzes the DLIF and XLIF Implants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application, Other Applications); End-Use (Hospitals End-Use, Outpatient Facilities End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Alphatec Holdings, Inc. (ATEC Spine)
  • Aurora Spine Corporation
  • B. Braun Melsungen AG
  • Captiva Spine, Inc.
  • Centinel Spine, LLC
  • CoreLink, LLC
  • Curiteva
  • DePuy Synthes (Johnson & Johnson)
  • Exactech, Inc.
  • Globus Medical, Inc.
  • K2M Group Holdings, Inc.
  • Life Spine, Inc.
  • LDR Holding Corporation
  • Medtronic plc
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • Osseus Fusion Systems
  • RTI Surgical Holdings, Inc.
  • SeaSpine Holdings Corporation
  • Spinal Elements, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • DLIF and XLIF Implants - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surge in Minimally Invasive Spine Surgeries Throws the Spotlight on DLIF and XLIF Implant Demand
    • Rising Geriatric Population Propels Growth of Lateral Interbody Fusion Procedures
    • Increasing Adoption of Outpatient and Same-Day Spine Surgeries Strengthens Business Case for Minimally Invasive Implants
    • Advancements in 3D-Printed Implant Designs Expand Addressable Market Opportunity for Patient-Specific Solutions
    • Integration with Robotic and Navigation Systems Drives Adoption in High-Precision Surgical Environments
    • Emergence of Biocompatible and Osteoinductive Materials Accelerates Demand for Next-Gen Implant Platforms
    • Shift Toward Value-Based Healthcare Models Spurs Demand for Clinically Effective and Cost-Efficient Implant Solutions
    • Rising Prevalence of Degenerative Disc Disorders Generates Sustained Need for Fusion-Based Therapeutic Interventions
    • Increasing Preference for Lateral Access Approaches Over Traditional Methods Drives Market Realignment
    • Expanding Surgeon Training and Educational Initiatives Sustain Growth in Procedural Volumes
    • Growing Use of AI and Machine Learning in Surgical Planning Tools Enhances Appeal of Implant-Supported Procedures
    • Demand for Shorter Hospital Stays and Quicker Recovery Times Spurs Shift Toward Minimally Invasive Implant Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World DLIF and XLIF Implants Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for DLIF and XLIF Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for DLIF and XLIF Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Degenerative Disc Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Degenerative Disc Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Degenerative Disc Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Spondylolisthesis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Spondylolisthesis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Spondylolisthesis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Scoliosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Scoliosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Scoliosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Outpatient Facilities End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Outpatient Facilities End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Outpatient Facilities End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • JAPAN
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • CHINA
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • EUROPE
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for DLIF and XLIF Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for DLIF and XLIF Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • FRANCE
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • GERMANY
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for DLIF and XLIF Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for DLIF and XLIF Implants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • INDIA
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for DLIF and XLIF Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for DLIF and XLIF Implants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for DLIF and XLIF Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for DLIF and XLIF Implants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • AFRICA
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION